Global Life Science Products Market 2020 and Forecast 2021-2026(Includes Business Impact of COVID-19)

                                          
The global Life Science Products market is valued at over 3175 million US$ in 2020 is expected to reach 4033million US$ by the end of 2026, growing at a CAGR of 4.9% during 2021-2026.

By product type, the antibodies segment dominated the global life science products market in terms of revenue in 2020 and is projected to continue to do so throughout the forecast period. The antibodies segment is expected to be the most attractive segment by product type during the forecast period.

By application, the basic research segment dominated the global life science products market in terms of revenue in 2017 and is projected to continue to do so throughout the forecast period.

By end user, the academic research institutes segment dominated the global life science products market in terms of revenue in 2020 and is projected to continue to do so throughout the forecast period.

This report focuses on Life Science Products volume and value at global level, regional level and company level. From a global perspective, this report represents overall Life Science Products market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered in this report.


 	
Merck Millipore Limited
 	
PerkinElmer
 	
Sigma Aldrich Corp
 	
Thermo Fisher Scientific
 	
Abcam
 	
A.M.S. Biotechnology (Europe)
 	
Bio-Rad Laboratories
 	
BPS Bioscience
 	
Crown Bioscience
 	
Genscript Biotech Corporation

The global life science products market is segmented as follows:

Life Science Products Market, by Product Type

Recombinant Proteins

 	
Immune Checkpoint Regulators
 	
Chemokines
 	
Growth Factors
 	
Cytokines
 	
Colony Stimulating Factors
 	
Hormones
 	
Enzymes and Inhibitors
 	
Others

Cell Lines

 	
Immunotherapy Cell Lines
 	
Ion Channel Cell Lines
 	
GPCR Cell Lines
 	
Cell Signaling Pathway Cell Lines
 	
Gene Knockout Cell Lines
 	
Cancer Cell Lines
 	
Others

Antibodies

 	
Immune Checkpoint Antibodies
 	
Epitope Tag Antibodies
 	
Isotype Control Antibodies
 	
Primary Antibodies
 	
Assay Antibodies
 	
Others

Viable Tumor Samples
Tumor Tissue Microarrays

Life Science Products Market, by Application

 	
Drug Discovery and Development
 	
Basic Research
 	
Toxicity Screening
 	
Biopharmaceutical Production
 	
Drug Screening
 	
Tissue Engineering
 	
Forensic Testing

Life Science Products Market, by End User

 	
Biopharmaceutical Companies
 	
Contract Research Organizations (CROs)
 	
Academic & Research Institutes
 	
Forensic Science Laboratories
 	
Food & Beverage Companies
 	
Diagnostic Centers
 	
Others

Life Science Products Market, by Region

 	
North America
 	
Latin America
 	
Europe
 	
Asia Pacific
 	
Middle East and Africa